The survey was administered by Cardiovascular Angiography and Interventions, in collaboration with the American College of Cardiology Interventional Council in May. It includes responses from 414 cardiac catheterization laboratory directors and interventional cardiologists in the United States. Survey results were published in the journal Catherization & Cardiovascular Interventions.
From March 15 to April 15, median percutaneous coronary intervention volumes dropped by 55 percent, and transcatheter aortic valve replacement volumes dropped by 64 percent compared to volumes in 2019.
About 20 percent of lab directors reported more deaths among patients waiting for transcatheter aortic valve replacement.
More articles on cardiology:
Median pay for 5 cardiology subspecialties
Top 10 cardiology stories in August
SUNY Downstate faces 4th lawsuit alleging inadequate cardiac patient care, retaliation against surgeons
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.